Creative Planning Marker Therapeutics, Inc. Transaction History

Creative Planning

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.26 - $0.46 $1,716 - $3,036	6,600 Added 3.77%	181,641 $60,000
Q4 2021 Feb 11, 2022	BUY	$0.95 - $1.72 $28,196 - $51,049	29,680 Added 20.42%	175,041 $166,000
Q3 2021 Nov 10, 2021	SELL	$1.68 - $2.88 $8,400 - $14,400	-5,000 Reduced 3.33%	145,361 $246,000
Q2 2021 Aug 04, 2021	SELL	$1.88 - $3.56 $20,680 - $39,160	-11,000 Reduced 6.82%	150,361 $420,000
Q1 2021 Apr 30, 2021	BUY	$1.47 - $3.29 $237,200 - $530,877	161,361 New	161,361 $361,000
Q2 2020 Jul 23, 2020	SELL	$1.69 - $2.79 $41,411 - $68,366	-24,504 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$1.59 - $3.35 $38,961 - $82,088	24,504 New	24,504 $47,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $292M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.